ESR1 and breast cancer: Tamoxifen, a selective-estrogen receptor modulator, is highly effective for breast cancer prevention among high-risk women1–3 and significantly reduces the risk of recurrence, second breast cancer, and mortality in the adjuvant setting among women diagnosed with estrogen receptor positive breast cancer4–6.